Precision BioSciences DTIL Stock
Precision BioSciences Price Chart
Precision BioSciences DTIL Financial and Trading Overview
| Precision BioSciences stock price | 6.59 USD |
| Previous Close | 7.17 USD |
| Open | 7.13 USD |
| Bid | 5.12 USD x 200 |
| Ask | 9.15 USD x 200 |
| Day's Range | 7.05 - 7.21 USD |
| 52 Week Range | 3.53 - 9.62 USD |
| Volume | 111.7K USD |
| Avg. Volume | 394.56K USD |
| Market Cap | 195.42M USD |
| Beta (5Y Monthly) | 1.245 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.32 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29.4 USD |
DTIL Valuation Measures
| Enterprise Value | 138.46M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.8064516 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.337343 |
| Price/Book (mrq) | 4.1330996 |
| Enterprise Value/Revenue | 3.073 |
| Enterprise Value/EBITDA | -3.939 |
Trading Information
Precision BioSciences Stock Price History
| Beta (5Y Monthly) | 1.245 |
| 52-Week Change | 59.33% |
| S&P500 52-Week Change | 15.74% |
| 52 Week High | 9.62 USD |
| 52 Week Low | 3.53 USD |
| 50-Day Moving Average | 7.82 USD |
| 200-Day Moving Average | 6.2 USD |
DTIL Share Statistics
| Avg. Volume (3 month) | 394.56K USD |
| Avg. Daily Volume (10-Days) | 202.63K USD |
| Shares Outstanding | 27.6M |
| Float | 25.46M |
| Short Ratio | 8.86 |
| % Held by Insiders | 8.02% |
| % Held by Institutions | 68.68% |
| Shares Short | 2.52M |
| Short % of Float | 9.34% |
| Short % of Shares Outstanding | 9.13% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -117.039% |
| Operating Margin (ttm) | -80.77% |
| Gross Margin | 100.00% |
| EBITDA Margin | -78.010% |
Management Effectiveness
| Return on Assets (ttm) | -19.37% |
| Return on Equity (ttm) | -135.14% |
Income Statement
| Revenue (ttm) | 45.06M USD |
| Revenue Per Share (ttm) | 2.21 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 45.06M USD |
| EBITDA | -35148000 USD |
| Net Income Avi to Common (ttm) | -53617000 USD |
| Diluted EPS (ttm) | -1.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 87.55M USD |
| Total Cash Per Share (mrq) | 3.17 USD |
| Total Debt (mrq) | 28.1M USD |
| Total Debt/Equity (mrq) | 62.04 USD |
| Current Ratio (mrq) | 12.822 |
| Book Value Per Share (mrq) | 1.713 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -51899000 USD |
| Levered Free Cash Flow (ttm) | -16252500 USD |
Profile of Precision BioSciences
| Country | United States |
| State | NC |
| City | Durham |
| Address | 302 East Pettigrew St. |
| ZIP | 27701 |
| Phone | 919 314 5512 |
| Website | https://precisionbiosciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 67 |
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
Q&A For Precision BioSciences Stock
What is a current DTIL stock price?
Precision BioSciences DTIL stock price today per share is 6.59 USD.
How to purchase Precision BioSciences stock?
You can buy DTIL shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Precision BioSciences?
The stock symbol or ticker of Precision BioSciences is DTIL.
Which industry does the Precision BioSciences company belong to?
The Precision BioSciences industry is Biotechnology.
How many shares does Precision BioSciences have in circulation?
The max supply of Precision BioSciences shares is 27.6M.
What is Precision BioSciences Price to Earnings Ratio (PE Ratio)?
Precision BioSciences PE Ratio is now.
What was Precision BioSciences earnings per share over the trailing 12 months (TTM)?
Precision BioSciences EPS is -1.32 USD over the trailing 12 months.
Which sector does the Precision BioSciences company belong to?
The Precision BioSciences sector is Healthcare.
Precision BioSciences DTIL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25996.76 USD — |
-0.72
|
3.03B USD — | 25949.48 USD — | 26172.12 USD — | — - | 3.03B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12778.32 USD — |
-0.69
|
— — | 12753.58 USD — | 12862.09 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6873.54 USD — |
-1.66
|
— — | 6841.27 USD — | 6974.62 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1292.25 USD — |
-1.24
|
— — | 1285.37 USD — | 1305.11 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
- {{ link.label }} {{link}}
